SCHEMBL6818202

SCHEMBL6818202

CCSc1cncc(C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 6/20 0.52
POLB P06746 1/20 0.52
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
LMNA P02545 1/20 0.47
DDO Q99489 1/20 0.47
RAB9A P51151 2/20 0.41
GAA P10253 2/20 0.41
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
RAF1 P04049 1/20 0.38
APEX1 P27695 1/20 0.38
HSD17B10 Q99714 2/20 0.37
PKM P14618 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL5741778 0.91 CYP2C9 (0.44) HCAR2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL7396814 0.86 CYP2C9 (0.49) HCAR2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL18485279 0.84 SIRT2 (0.50) CYP2C9CYP2C19KDM4ERAB9AGAA
SCHEMBL20992876 0.79 HCAR2 (0.57) HCAR2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL30543639 0.79 HCAR2 (0.57) HCAR2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL13451125 0.79 TPMT (0.43) CYP2C9CYP2C19ALDH1A1KDM4EMEN1
SCHEMBL27632854 0.77 KDM6B (0.49) HCAR2POLBCYP2C9ALDH1A1KDM4E
SCHEMBL31113334 0.77 CYP2C9 (0.43) HCAR2POLBCYP2C9CYP2C19ALDH1A1
Butane SCHEMBL11036256 0.77 CYP2C9 (0.67) HCAR2POLBCYP2C9CYP2C19ALDH1A1
SCHEMBL4299731 0.75 HCAR2 (0.52) HCAR2POLBCYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3061758-B1 5-SUBSTITUTED ISOINDOLINE COMPOUNDS CELGENE CORP (US) 2018-01-31 EP disclosed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 HCAR2 344/4885POLB 637/4885CYP2C9 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.